Cambridge, MA (June 30, 2022) – Particles for Humanity has selected the final product and manufacturing process for its stable form of vitamin A, PFH-VAP, to be used. This achievement is a major milestone in the grant, triggering a payment of $1 million.

‘Particles for Humanity’ and LIS by Lesaffre successfully manufacture commercial scale batches of stable Vitamin A
Particles for Humanity, in partnership with LIS by Lesaffre, successfully manufactured commercial scale batches of PFH-VAP, the company’s lead product. PFH-VAP was designed to improve vitamin A stability for use in large scale food fortification, an intervention proven to address micronutrient deficiencies at scale.